EP
Elkhorn Partners Portfolio holdings
AUM
$138M
This Quarter Return
+0.22%
1 Year Return
+1.6%
3 Year Return
+7.74%
5 Year Return
+48.56%
10 Year Return
+43.22%
AUM
$156M
AUM Growth
+$156M
(-1%)
Cap. Flow
-$2.36M
Cap. Flow
% of AUM
-1.52%
Top 10 Holdings %
Top 10 Hldgs %
91.18%
Holding
41
New
–
Increased
7
Reduced
10
Closed
4
Top Buys
| 1 |
Kennedy-Wilson Holdings
KW
|
$212K |
| 2 |
Energy Recovery
ERII
|
$157K |
| 3 |
Cardiff Oncology
CRDF
|
$79K |
| 4 |
White Mountains Insurance
WTM
|
$59.1K |
| 5 |
Opko Health
OPK
|
$54.9K |
Top Sells
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
$738K |
| 2 |
BP
BP
|
$346K |
| 3 |
American International
AIG
|
$306K |
| 4 |
Carlyle Group
CG
|
$294K |
| 5 |
Gilead Sciences
GILD
|
$212K |
Sector Composition
| 1 | Real Estate | 49.84% |
| 2 | Financials | 37.39% |
| 3 | Utilities | 4.17% |
| 4 | Energy | 1.79% |
| 5 | Communication Services | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVR Energy
CVI
$3.07B
| $303K | 0.19% |
11,700
-5,700
| -33% | -$148K |
|
27
Taylor Devices
TAYD
$154M
| $301K | 0.19% |
24,500
| – | – |
|
28
FibroGen
FGEN
$47.8M
| $258K | 0.17% |
4,800
-3,500
| -42% | -$188K |
|
|
OBE
29
Obsidian Energy
OBE
$413M
| $249K | 0.16% |
237,000
| – | – |
|
|
VXX
30
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $246K | 0.16% |
6,275
-18,825
| -75% | -$738K |
|
|
PLM
31
DELISTED
PolyMet Mining Corp.
PLM
| $235K | 0.15% |
386,000
| – | – |
|
|
32
Opko Health
OPK
$1.1B
| $230K | 0.15% |
33,500
+8,000
| +31% | +$54.9K |
|
|
33
Cardiff Oncology
CRDF
$140M
| $212K | 0.14% |
290,000
+108,000
| +59% | +$79K |
|
34
Reading International Class A
RDI
$35M
| $160K | 0.1% |
10,200
| – | – |
|
35
Innodata
INOD
$1.21B
| $115K | 0.07% |
76,629
| – | – |
|
36
Fuel Tech
FTEK
$90.7M
| $46K | 0.03% |
45,000
| – | – |
|
|
VVUS
37
DELISTED
Vivus Inc
VVUS
| $11K | 0.01% |
11,300
| – | – |
|
|
38
American International
AIG
$45.1B
| – | – |
-4,900
| Closed | -$306K |
|
|
39
Carlyle Group
CG
$23.4B
| – | – |
-14,900
| Closed | -$294K |
|
|
40
Gilead Sciences
GILD
$140B
| – | – |
-3,000
| Closed | -$212K |
|
41
ProShares UltraShort S&P500
SDS
$445M
| – | – |
-13,000
| Closed | -$165K |
|